Inventor · disambiguated record
Maria E. Wilson
Also filed as: WILSON MARIA E
8 granted patents·3 pending applications·68 citations·filing 2004–2017
86Inventor score
Top patents by PatentIndex Score
11 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0291US8227495B22,4-disubsituted thiazoles and pharmaceutical compositions thereofCHEN XIN·Filed 2009·Granted Jul 24, 2012·13 cites·18 claims
- 0389US8288384B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2009·Granted Oct 16, 2012·9 cites·1 claims
- 0478US9737537B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·1 cites·2 claims
- 0567US9925189B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·2 claims
- 0664US8921350B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCYMABAY THERAPEUTICS INC·Filed 2013·Granted Dec 30, 2014·0 cites·4 claims
- 0763US7556930B2CD39L3 and its role in diabetesMETABOLEX INC·Filed 2006·Granted Jul 7, 2009·2 cites·6 claims
- 0861US8975258B2Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2012·Granted Mar 10, 2015·0 cites·22 claims
- 0956US2015239881A1Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersCHEN XIN·Filed 2015·Application pending·0 cites
- 1051US2009270404A1Oxymethylene aryl compounds and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 1142US2005186582A1Compositions and methods of using hexokinase VMETABOLEX INC·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →